Pure Global
AI-powered global market access for MedTech companies.
Quick facts
- Best for
- AI-powered global market access for MedTech companies.
- Pricing
- Freemium
- Editor rating
- 4.5 / 5
- Community saves
- 0
About Pure Global
Pure Global provides comprehensive solutions designed to meet regulatory compliance and market access requirements for MedTech companies. Leveraging AI and data, Pure Global offers smart and efficient services to ensure product readiness for market entry and continued compliance post-launch, by securing necessary approvals and certifications from regulatory bodies. The company's services extend to facilitating market access by local representation efforts in key markets worldwide and providing support for attainment and maintenance of market access. They are equipped to provide expert analysis, monitor regulatory trends across more than 100 countries, and provide detailed data for product classification, standards, and essential specifications. Additionally, Pure Global provides end-to-end clinical trial management services covering pre-market development to post-market surveillance. Services are customized to cater to different types of clientele from startups to multinational enterprises within the medical device and in vitro diagnostics manufacturers. As a global regulatory intelligence platform, Pure Global can support clients in navigating through global healthcare markets effectively.
Pros
- Regulatory compliance services
- Supports market entry
- Continued post-launch compliance
- Secures necessary approvals/certifications
- Local market representation
- Monitoring of regulatory trends
- Operations in 100+ countries
- Detailed product data
- Clinical trial management services
- Customized services
- Startups to multinational clients
- Global regulatory intelligence platform
Cons
- Lacks cybersecurity for medical devices
- No tech integration for enterprises
- Limited pre-submission activities support
- Need more data on products
- No established global presence
- Lack of tailored solutions
- Limited detailed data provision
- Clinical trial management limitations
- Services not fully customized
- Restricted to Med
- Tech companies
